Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Cash from Investing Activities (2016 - 2025)

United Therapeutics (UTHR) has disclosed Cash from Investing Activities for 17 consecutive years, with -$227.6 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 84.74% to -$227.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$551.3 million through Dec 2025, down 232.14% year-over-year, with the annual reading at -$551.3 million for FY2025, 232.14% down from the prior year.
  • Cash from Investing Activities hit -$227.6 million in Q4 2025 for United Therapeutics, down from $140.9 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $735.3 million in Q1 2024 to a low of -$359.2 million in Q1 2022.
  • Historically, Cash from Investing Activities has averaged -$107.6 million across 5 years, with a median of -$166.9 million in 2022.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 5601.59% in 2022 and later surged 432.56% in 2024.
  • Year by year, Cash from Investing Activities stood at -$195.8 million in 2021, then grew by 3.32% to -$189.3 million in 2022, then skyrocketed by 122.24% to $42.1 million in 2023, then crashed by 392.64% to -$123.2 million in 2024, then crashed by 84.74% to -$227.6 million in 2025.
  • Business Quant data shows Cash from Investing Activities for UTHR at -$227.6 million in Q4 2025, $140.9 million in Q3 2025, and -$299.9 million in Q2 2025.